The U.S. Food and Drug Administration said Thursday it can’t regulate CBD supplements because there isn’t enough evidence on their safety. The agency also called on Congress to create new rules for what has become a burgeoning industry. “The use of CBD raises various safety concerns, especially with long-term use,” FDA Deputy Commissioner Dr. Janet Woodcock said in a statement. “Studies have shown the potential for harm to the liver, interactions with certain medications and possible harm to the male reproductive system. CBD exposure is also concerning when it comes to certain vulnerable populations such as children and those who are pregnant.” “The FDA’s existing foods and dietary supplement authorities provide only limited tools for managing many of the risks associated with CBD products,” Woodcock added. “Given the available evidence, it is not apparent how CBD products could meet safety standards for dietary supplements or food additives.” “For example, we have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” Woodcock noted. “Therefore, we do not intend to pursue rule-making allowing the use of CBD in dietary supplements or conventional foods.” Meanwhile, the FDA has warned some companies about making health claims for the ingredient, which the agency said it plans to continue doing. How to regulate CBD supplements has become a pressing public health… read on > read on >

















